Trademark: ASSUREX 1739656
Word
ASSUREX
ID
1739656
Trademark Type
Word
Status
Registered: Registered/protected
Application Date
07 December 2015
Registration Date
07 December 2015
Renewal Date
07 December 2025
Owner(s)
Service
Herbert Smith Freehills
Goods and Services:
Class 39:
Storage and provision of DNA samples for future studies, collaborations and development and validation of new products
Storage and provision of DNA samples for future studies, collaborations and development and validation of new products
Class 44:
Providing personalized healthcare and medical information, including, providing medical information and reports that will enable doctors and clinicians to select and recommend the appropriate treatment for patients through the use of data obtained through personalized pharmacogenetics, proteomics and other biological testing, individual behaviors including medication compliance, exercise diet, sleep patterns and language, epigenetic and environmental factors, and bioinformatics analysis; and consultation services related thereto; medical testing services for diagnostic and treatment purposes, including, providing medical tests that measure, analyze and interpret genes of patients, environmental and other factors to predict which drugs and/or treatment programs have the best opportunity for positive outcomes for patients, personalize medication selection and treatment options and choices for patients, identify potentially harmful drug interactions and calculate drug dosage adjustments for patients; providing medical information to patients and medical professionals in the form of reports for the foregoing medical testing services; bioinformatics analysis and consultation services relating to pharmacogenomics and genetic testing
Providing personalized healthcare and medical information, including, providing medical information and reports that will enable doctors and clinicians to select and recommend the appropriate treatment for patients through the use of data obtained through personalized pharmacogenetics, proteomics and other biological testing, individual behaviors including medication compliance, exercise diet, sleep patterns and language, epigenetic and environmental factors, and bioinformatics analysis; and consultation services related thereto; medical testing services for diagnostic and treatment purposes, including, providing medical tests that measure, analyze and interpret genes of patients, environmental and other factors to predict which drugs and/or treatment programs have the best opportunity for positive outcomes for patients, personalize medication selection and treatment options and choices for patients, identify potentially harmful drug interactions and calculate drug dosage adjustments for patients; providing medical information to patients and medical professionals in the form of reports for the foregoing medical testing services; bioinformatics analysis and consultation services relating to pharmacogenomics and genetic testing